Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension, dilate the pupil, and induce local vasoconstriction. The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.
Phenylephrine was granted FDA approval in 1939.
Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation is used to treat hemorrhoids. Off-label uses include priapism and induction of local vasoconstriction.
University of Chicago Medical Center, Chicago, Illinois, United States
Novant Health Forsyth Medical Center, Winston-Salem, North Carolina, United States
Duke University Medical Center, Durham, North Carolina, United States
Samsung medical center, Seoul, Korea, Republic of
New York Medical College/Bradhurst Building, Hawthorne, New York, United States
University of Manitoba, Winnipeg, Manitoba, Canada
University Medical Center Groningen, Groningen, Netherlands
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Naestved Hospital, Naestved, Denmark
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.